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resumo 
 
Apesar de a diabetes tipo 1 ser uma das formas mais raras 
de diabetes mellitus, tem uma origem auto-imune e aparece 
precocemente na vida de um indivíduo afectando 
grandemente a qualidade da mesma. No sentido de melhor 
compreender os mecanismos moleculares subjacentes às 
alterações fenotípicas observadas no músculo esquelético 
dos pacientes diabéticos, delineou-se um protocolo 
experimental com 20 ratos Wistar com 8 semanas de idade, 
aleatoriamente divididos em dois grupos (n=10). Os animais 
de um dos grupos foram injectados com 60mg/Kg de 
streptozotocina (STZ), e os outros com veículo. Após 4 
meses, os ratos injectados com STZ foram confirmados 
como diabéticos, tendo em consideração a hiperglicemia e a 
perda de massa corporal. Após o sacrifício dos animais 
foram retirados os músculos gastrocnemius, a partir dos 
quais foram isoladas as duas subpopulações mitocondriais 
(subsarcolemal (SS) e intermiofibrilar (IMF)). A análise da 
razão mtADN-massa muscular sugere que a administração 
de STZ induziu o aumento da biogénese mitocondrial SS 
associado a um decréscimo do teor proteico mitocondrial, ao 
contrário do observado nas mitocôndrias IMF. O perfil de BN-
PAGE revelou uma ligeira diferença entre a organização dos 
complexos da fosforilação oxidativa entre ambas as 
subpopulações mitocondriais, aparentemente não afectada 
pela administração de STZ. A análise da proteólise 
mitocondrial, efectuada por zimografia, evidenciou duas 
proteases com 15 e 25 KDa, tendo-se observado uma 
diminuição acentuada da actividade da protease com menor 
peso molecular nas mitocôndrias IMF dos animais 
diabéticos. Uma tendência semelhante foi observada para a 
expressão da subunidade paraplegina do sistema proteolítico 
m-AAA e para a mitofilina, uma proteína envolvida na 
organização da membrana interna mitocondrial. 
Curiosamente, nas mitocôndrias SS dos animais diabéticos 
verificaram-se níveis mais elevados destas proteínas.  
Com este estudo verificou-se que no gastrocnemius, as 
mitocôndrias IMF são mais afectadas pela diabetes mellitus 
tipo 1 do que as SS. A diminuição da actividade do sistema 
de controlo da qualidade proteica parece estar associada às 
alterações morfológicas e bioquímicas observadas nas 
mitocôndrias localizadas entre as fibrilas. 
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abstract 
 
Despite type 1 diabetes mellitus being more rare, it has an 
autoimmune origin and appears early in life, greatly affecting its 
quality. With the aim of better understand the molecular 
mechanisms underlying the observed phenotypic alterations in 
the skeletal muscle from diabetic patients, it was planned an 
experimental protocol using 20 Wistar rats 8 weeks old, 
randomly divided in two groups (n=10). The animals from one 
group were injected with 60mg/Kg of streptozotocin (STZ), while 
the others were injected with vehicle buffer. Four months after 
STZ injection, rats were confirmed as diabetic, considering 
hyperglycemia and body weight loss. After animals sacrifice, 
gastrocnemius muscles were excised and used for mitochondria 
subpopulations (subsarcolemmal (SS) and intermyofibrillar 
(IMF)) isolation. mtDNA-to-muscle mass ratio suggest an 
increased biogenesis of SS mitochondria in the STZ animals, 
paralleled by a decreased protein content per mitochondrion, in 
opposite to the observed in IMF mitochondria. The BN-PAGE 
profile revealed a slight difference of the oxidative 
phosphorylation complexes organization between mitochondrial 
subpopulations, apparently not affected by STZ administration. 
Mitochondrial proteolysis analysis, evaluated through 
zymography, revealed two proteases with molecular weights 
around 15 and 25 KDa, with the smaller one presenting STZ-
induced significant decreased activity in IMF mitochondria. A 
similar behavior was observed for paraplegin, a subunit of m-
AAA proteolytic system, and mitofilin, a protein involved in 
cristae organization. Interestingly, these protein levels were 
higher in SS mitochondria from diabetic animals. 
With this work it was verified that subsarcolemmal mitochondria 
are not so affected by STZ administration as IMF mitochondria. 
The decreased activity of the protein quality control system 
seems to be associated with the morphological and biochemical 
alterations observed in the mitochondria interspersed in fibrils. 
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1. Introduction  
___________________________________________________________________
Introduction 
 
 
In 2010, it was estimated that 6.4% of the world adult population was 
affected with diabetes mellitus. This number is expected to increase year by year, 
reaching, in 2030, 7.7% of the adult population, being one of the major causes of 
premature illness and death worldwide [1]. This reality has motivated several 
studies in order to comprehend the molecular mechanisms involved in this 
pathophysiology [2]. Type 1 diabetes mellitus (T1DM) is not the biggest 
responsible for these numbers, neither the most studied type of diabetes mellitus, 
but since it has an autoimmune origin, and its patients have decreased life quality 
[3], it seems urgent to better understand this disease. 
The diagnosis of T1DM is made through evident first signs like polyuria, 
weight loss and the constant tiredness, these signs are related with the high 
concentration of blood glucose and the lack of cell glucose, needed for energy 
production [4]. To compensate this glucose deficit, cell metabolizes lipids in order 
to produce the needed energy, which in advanced phases of T1DM causes diabetic 
ketoacidosis [5]. The treatment consists in the injection of insulin, in order to 
regulate the blood levels of glucose [4], which should be accompanied with 
appropriate physical exercise and low carbohydrate diets [6]. When not treated, 
T1DM can cause serious complications like cerebral stroke, renal failure, visual 
problems, including blindness, difficult to heal injuries and even myocardial 
infarction [5]. 
Due to its metabolic dependence on insulin, skeletal muscle is one of the 
most affected organs by T1DM, which account for 42% of body weight. In order to 
better understand the molecular pathways involved in muscle T1DM-induced 
functional alterations which compromise patients’ quality of life [7], studies 
focused on muscle bioenergetic alterations and associated regulatory mechanisms 
seem urgent [8]. Mitochondria play a very important role in the skeletal muscle 
bioenergetics, making them an appellative target of study focused on skeletal 
muscle physiopathologies like diabetes. 
Type 1 diabetes mellitus effects on mitochondrial function 
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1.1. Mitochondrial origin, structure and function 
Mitochondria are essential cellular organelles that provide the majority of 
the energy necessary for cell and tissue functions. It is present in all eukaryotic 
cells, and a typical human cell has several hundreds of mitochondria [9]. 
Mitochondria size range between 0.5-1 µm and have two membranes. The outer 
membrane is smooth and contains several transport proteins, which forms aqueous 
channels allowing some molecules to penetrate the membrane. The inner membrane 
is formed by multiple invaginations, forming the cristae which can be tubular or 
lamellar (Figure 1). 
 
Figure 1: Schematic representation of mitochondria and its 
compartments [10]. 
Currently, the most accepted theory of mitochondrial origin is that present 
mitochondria are a remnant of a symbiotic relationship between a prokaryotic 
organism and another cell, creating the eukaryotic cell [11]. In 1997, Lang et al. 
[12] studied the protozoon Reclinomonas americana, which has the most similar 
genome to mitochondria. One year later, in 1998, Andersson et al. [13] studied 
Rickettsia prowazekii the most mitochondria-like eubacterial genome. Current 
theories also state that no eukaryote exists without mitochondria in it, indicating 
that the insertion of the symbiont protobacteria into the anaerobic host effectively 
improved respiration, causing them to sustain this symbiotic relationship [9; 11]. 
Mitochondria produce energy through a metabolic pathway composed by 
five complexes, called the oxidative phposphorylation (OXPHOS), which occurs in 
the mitochondrial inner membrane that surrounds the matrix space of each 
mitochondrion. This organelle matrix contains mitochondrial DNA (mtDNA), 
Introduction 
tRNAs, ribosomes and various enzymes used for protein synthesis, pyruvate 
oxidation, for the citric acid cycle and for the oxidation of fatty acids which 
combined with other proteins makes about 1500 proteins per mitochondrion, most 
of which encoded in the nucleus [10; 14]. Mitochondria are also responsible for 
several other important functions like heat production, calcium storage and 
signaling contributing for cell’s homeostasis, regulation of the cell membrane 
potential, cell apoptosis, cellular proliferation and metabolism, steroids synthesis 
and certain heme synthesis reactions [15; 16; 17]. 
Since mitochondria are the main ATP suppliers of the cell, they have a very 
important role in cellular metabolism, cell apoptosis and are the largest producers 
of ROS in the organism, which has a significant role in the aging process [18; 19; 
20]. Therefore, any disturbance in mitochondrial homeostasis, will compromise the 
cell’s homeostasis or, if a tissue suffers any disturbance, mitochondria will have to 
adapt to balance its homeostasis [18; 21; 22] 
 
1.2. Mitochondrial OXPHOS complexes organization 
OXPHOS is a cellular pathway which consists in the activity of five 
complexes, with about 90 already known protein subunits [23]. Most of these 
subunits are encoded in the nuclear genome, while 13 of them are encoded in the 
mtDNA [24] (Table 1).  
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Table 1: Mitochondrial genome codified proteins from Rattus norvegicus. List 
obtained from Genome database (http://www.ncbi.nlm.nih.gov/sites/entrez), access 
number NC_001665. 
Codified protein Length GeneID Locus 
NADH dehydrogenase subunit 1 318 26193 ND1 
NADH dehydrogenase subunit 2 346 26194 ND2 
cytochrome c oxidase subunit I 514 26195 COX1 
cytochrome c oxidase subunit II 227 26198 COX2 
ATP synthase F0 subunit 8 67 26196 ATP8 
ATP synthase F0 subunit 6 226 26197 ATP6 
cytochrome c oxidase subunit III 261 26204 COX3 
NADH dehydrogenase subunit 3 115 26199 ND3 
NADH dehydrogenase subunit 4L 98 26200 ND4L 
NADH dehydrogenase subunit 4 459 26201 ND4 
NADH dehydrogenase subunit 5 609 26202 ND5 
NADH dehydrogenase subunit 6 172 26203 ND6 
cytochrome b 380 26192 CYTB 
 
These OXPHOS complexes are located in the inner mitochondrial 
membrane, and are organized as described in Figure 2. 
 
Figure 2: Representation of the electron transport chain within mitochondria, where the succinate 
and the NADH produced in citric acid cycle, give their electrons whose enter in an electron flow, with 
the final objective to produce ATP. Adapted from [25]. 
 
Introduction 
Resulted products from citric acid cycle, fatty acid β-oxidation and amino-
acid oxidation, are used to produce ATP within mitochondria. At the mitochondrial 
inner membrane, electrons from reduced nicotinamide adenine dinucleotide 
(NADH) and succinate are transferred, respectively to complex I (CI) and complex 
II (CII), starting the electron transport chain (ETC). The ETC comprises an 
enzymatic series of electron donors and acceptors. Each electron donor passes 
electrons to a more electronegative acceptor, which in turn donates these electrons 
to another acceptor, a process that continues down the series until electrons are 
passed to oxygen, the most electronegative and terminal electron acceptor in the 
chain, which is reduced to water. Both complexes I and II transfer their pair of 
electrons to complex III (CIII), using coenzyme Q (CoQ) as intermediate receptor. 
Cytochrome c (CytC) also works as mobile carrier of electron, transporting them 
from CIII to complex IV (CIV), which one gives electron to the final receptor, the 
oxygen, reducing it into water. In each ETC complex, passages of electrons 
between donor and acceptor releases energy, which is used to generate a proton 
gradient across the mitochondrial membrane by actively pumping protons into the 
intermembrane space, producing a thermodynamic state that has the potential to do 
work. This potential created by an increased concentration of H
+
 in the 
intermembranar space will be used by complex V (CV) to produce ATP, through 
the passage of these protons back into the mitochondrial matrix. A small percentage 
of electrons do not complete the whole series and instead directly leak to oxygen, 
resulting in the formation of ROS [25; 26; 27]. 
The organization of the respiratory chain complexes within the lipid bilayer 
is still not fully known. There are two main explanations for the interactions 
between complexes: the fluid state and the solid state models. The fluid state 
organization model supports that all five complexes exist as independent complexes 
which randomly diffuse within the lipid bilayer. Electron transfer between the 
complexes is supported through their collisions while diffusing in the membrane, 
and where coenzyme Q and cytochrome c, would exhibit faster diffusion rates 
relative to the larger membrane-embedded, multisubunit complexes. On the other 
hand, the solid state favors that a higher-level of organization of the OXPHOS 
complexes exists within the inner membrane which promotes directed electron 
channeling between physically associated OXPHOS complexes [28]. Studies where 
Type 1 diabetes mellitus effects on mitochondrial function 
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the purifications of the OXPHOS complexes was performed with detergents into 
their individually active forms, demonstrates that their co-association in the 
membrane is not necessary for their enzymatic function [28]. However, a number of 
independent studies have demonstrated that the mitochondrial OXPHOS complexes 
can be co-purified together when solubilized from the mitochondrial membranes 
with detergents like digitonin [29]. The demonstration of purified OXPHOS 
supercomplexes formed by the physical association of proteins between these 
complexes and thus uniting them into a higher level of organization, favors that the 
OXPHOS complexes are not randomly organized as individual complexes in the 
membrane, as the liquid state model would predict, proposing that the different 
respiratory complexes are assembled into supramolecular structures, called 
supercomplexes, to perform their role [28]. The solid state model is sustained 
almost exclusively on consistent and repetitive observations showing the 
electrophoretic comigration of different respiratory complexes using native gels or 
centrifugation density gradients [25]. Since all the respiratory complexes are 
integral components of the mitochondrial inner membrane, their extraction requires 
the disorganization of this membrane. It has been reported that the more abundant, 
stable, and more easily purified supercomplex contains complexes I and III but not 
complex IV, and hence its functional role is difficult to envision, although the 
association of complex II in supercomplexes, has never been described [30]. 
Furthermore, it remains to be proved that the electrons are transferred between 
complexes within the supercomplex and, more important, that the supercomplexes 
containing CI, CIII, and CV are able to take electrons from NADH and use them to 
reduce oxygen. Therefore, the existence of respiratory supercomplexes in 
mitochondria as functional entities is far from being demonstrated [25].  
Due to its role in cell bioenergetics, this complex mitochondrial machinery 
needs to be under tight control, being protein quality control systems of major 
importance in this process. 
 
 
Introduction 
1.3. Protein quality control within mitochondria: the role of 
mitochondrial proteases 
Protein quality control (QC) system within mitochondria has a great 
importance for cell survival, because when seriously damaged mitochondria 
produce more ROS, having low productivity in ATP synthesis [31] and may release 
pro-apoptotic proteins, inducing cell apoptosis [32]. 
Protein QC provides the first line of defense within mitochondria, being a 
highly conserved proteolytic system [33]. Molecular chaperones and energy-
dependent proteases monitor the folding and assembly of mitochondrial proteins 
and selectively remove excess and damaged proteins from the organelle [31]. A 
second line of defense is provided at the organellar level by the dynamic nature of 
the mitochondrial population of a cell, where the functionality of damaged 
mitochondria can be restored by fusion with neighboring undamaged mitochondria 
[34]. 
The mitochondrial QC system has both the function of monitoring newly 
synthesized proteins proper folding and correct assembly, and selectively 
recognizing non-native, misfolded or non-assembled proteins, in order to remove 
and degrade them [31; 35]. The proteases from the QC quality control system, 
degrade damaged proteins to peptides, which are subsequently either exported from 
the organelle or degraded further to amino acids by various oligopeptidases (Figure 
3) [31]. The protein folding and its proper function depends on each other, being 
the first one monitored as soon as the protein is synthesized, ant takes place in all 
cellular compartments [36]. Damaged proteins are mainly a consequence of ROS 
production, mutations or misfoldings, being its removal and degradation a very 
important function; otherwise its accumulation leads to cell aging, malfunction and 
death [37]. 
Type 1 diabetes mellitus effects on mitochondrial function 
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Figure 3: QC applied to mitochondrial proteins. ATP-dependent 
proteases present in various mitochondrial compartments recognize non-
native polypeptides and trigger their proteolysis to peptides that are 
further degraded by oligopeptidases. At the same time, energy-dependent 
proteases can act as processing enzymes ensuring assembly and integrity 
of OXPHOS complexes [31]. 
 
QC within mitochondria is, by one side, monitored by nuclear-encoded 
chaperones, that help proteins achieve their proper tertiary structure, and by other 
side, by proteases which function is to degrade proteins that fail to fold to properly 
oligomerize [31] or become damaged [38], where the central role of this last 
described QC function, belongs to the a superfamily of proteases, the ATPases 
associated with a variety of cellular activities (AAA
+
), which is characterized by a 
conserved module present in all of these proteases [31]. These proteins are present 
in each of the four mitochondrial compartments, recognizing misfolded, solvent-
exposed domains of substrates, loops of multispanning membrane proteins, or short 
N- or C-terminal tails protruding from the lipid bilayer [39], having the task to fold 
and assembly unfolded and misfolded proteins that can accumulate in each of these 
four compartments (Figure 4) [38]. 
 
Introduction 
 
Figure 4: QC proteases monitor the four mitochondrial compartments. 
Localized QC proteases monitor and protect all four mitochondrial 
compartments against deleterious accumulation of misfolded, misassembled or 
unfolded proteins [38]. 
 
As observed in Figure 4, in the IM there are two AAA proteins, one with its 
active site turned to the IMS, the i-AAA, and another one with its active site turned 
into to the mitochondrial matrix, the m-AAA, being both the prime targets of 
mitochondrial ROS [31]. Both of these proteases mediate the ATP-dependent 
dislocation of substrate proteins from the membrane allowing their degradation in a 
hydrophilic environment [39]. 
As a member of the QC system [40], m-AAA can be organized in hetero- or 
homo-oligomeric assemblies [41], being an integral membrane protein, playing a 
central role in the polypeptides transport through the IM [42]. Within mitochondria, 
m-AAA proteases have versatile activities, being not only quality control enzymes 
that completely degrade non-assembled or misfolded polypeptides [40], but can 
also act as processing enzymes specifically cleaving mitochondrial proteins with 
regulatory functions, having a chaperone-like activity [33; 41]. In addition to its 
function in QC, m-AAA proteases control directly the biogenesis of the OXPHOS 
complexes. As described by Nolden et al. [43], MrpL32 is a nuclear encoded 
subunit of mitochondrial ribosomes, which is matured by m-AAA proteases, having 
in this case, the role of processing this ribosomal subunit and not of a QC enzyme 
(Figure 5a). Being MrpL32 processing a prerequisite for its assembly into 
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ribosomes and activation of mitochondrial translation, the m-AAA protease directly 
regulates the synthesis of mtDNA-encoded OXPHOS subunits within mitochondria 
[31]. It is important to note that both regulatory and QC functions of the m-AAA 
protease are interdependent and may compete with each other, because while m-
AAA is degrading its accumulated substrates, resulted from aging and ROS 
production, this protease will not be assembling MrpL32, resulting in an inhibition 
of OXPHOS proteins translation [43]. The m-AAA protease is also related to a 
protective function, regarding OXPHOS complexes, mediating maturation of the 
ROS scavenger cytochrome c peroxidase (Ccp1) in the mitochondrial 
intermembrane space, where Ccp1 is processed by the m-AAA protease and the 
rhomboid protease Pcp1(Figure 5b), an intramembrane-cleaving peptidase in the 
inner membrane [44]. 
 
Figure 5: Regulation of OXPHOS complexes assembly and maintenance by proteases. (a) The assembly 
of mitochondrial ribosomes and synthesis of mitochondrially encoded RC subunits require maturation of 
newly imported MrpL32 by the m-AAA protease. (b) Biogenesis of the ROS scavenger Ccp1 in yeast 
mitochondria depends on ATP-dependent membrane dislocation of the precursor protein by the m-AAA 
protease and maturation by the rhomboid protease Pcp1 [31]. 
 
Paraplegin is a subunit of the hetero-oligomeric m-AAA protease, localized 
in the inner mitochondrial membrane, with the active site in the mitochondrial 
matrix [45], as shown in Figure 4 and Figure 5. Paraplegin has three domains, 
where one of them has an AAA
+
 module, making paraplegin part of the AAA
+
 
superfamily [46]. Also, this protein forms cylindrical hetero-hexamers to become 
active, a known feature from AAA
+
 proteins family [47]. The m-AAA protein 
complex is both responsible for QC in the IM and protein activation [48], and 
specifically, paraplegin is involved in misfolded proteins degradation, cleavage of 
mitochondrial targeting sequences, mitochondrial ribosome maturation [43] and is 
Introduction 
also linked to the proteolytic processing of OPA1, a GTPase in the IM, which 
alteration cause optical atrophy [49]. 
Given the protective functions of mitochondrial QC, it is not surprising that 
pathological alterations of its key components has been described for an increasing 
number of neurodegenerative disorders [31], although the involvement of QC 
system was not yet reported for diabetes mellitus-induced mitochondriopathy. 
 
1.3.1. Regulation of mitochondrial cristae morphology 
Mitochondrial cristae and m-AAA proteases depend on each other, since m-
AAA exist in mitochondrial cristae, and the cristae need the QC proteins like m-
AAA to control the quality of the IM proteins that regulate cristae biogenesis, such 
as mitofilin [50] and OPA1 [51; 52] 
The ultrastructural variations in mitochondria architecture occur mainly due 
to differences in the amount and shape of the cristae, which derive from the 
unfolded inner membrane where OXPHOS complexes and intermediate metabolic 
proteins are embedded. Mitochondria can adapt remarkably well to the energetic 
needs by altering their metabolism, which is accompanied by structural changes of 
the inner membrane. For example, abundant cristae are found in mitochondria from 
tissues where energy demand is high [53]. In the maintenance of mitochondrial 
cristae organization and the consequent assembly of OXPHOS, other proteins 
besides QC systems are involved [54]. Mitofilin is an integral membrane protein of 
the inner mitochondrial membrane, expressed in two isoforms with 88 and 90KDa, 
that differ in 11 amino acid residues [53; 55], generated through alternative splicing 
[55]. John et al. [53] observed that mitofilin downregulation results in drastic 
changes in the inner mitochondrial membrane, such as the absence of cristae 
junctions and the loss cristae traditional structure into concentric layers that 
interconnect at numerous sites. These authors also observed an increment of 
IM:OM ratio, suggesting a loss of inner membrane configuration and IM 
biogenesis, but with a defective OXPHOS, that lead to an increment of membrane 
potential and a high ROS production, resulting in a weak ATP production. Is this 
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work, they concluded that mitofilin is an indispensable part of mitochondrial 
morphogenetic machinery. 
 
1.4. Mitochondrial biogenesis in the striated muscle 
The energetic metabolism of skeletal muscle consists mostly in the 
oxidation of carbohydrates and lipids within mitochondria, being glycogen, the 
major carbohydrate substrate for ATP production. Rarely, amino acids from protein 
degradation can be also used as energy source [56]. Also, an anaerobic metabolism 
is constant within muscle cells, turning glucose into lactate, and only used in higher 
ratios when a quick and enormous amount of energy is needed [57], even with the 
high mitochondrial concentration of this tissue [58]. 
Mitochondrial protein content varies from organ to organ [59], and in 
striated muscle there is the added dimension of two populations of mitochondria: 
subsarcolemmal (SS) mitochondria, which exist under the sarcolemma, and 
intermyofibrillar (IMF) mitochondria, which exist trapped into the myofibrils [60; 
61; 62]. Several studies reported that the two mitochondrial subpopulations have 
different and specific roles in producing ATP for the cell [19; 20; 22]. For instance, 
IMF mitochondria are involved in the production of energy for contractile activity, 
whereas SS mitochondria provide energy for membrane and transport functions 
(Figure 6) [20]. Also, the metabolic differences between these mitochondrial 
subpopulations may play an important role with functional and physiological 
consequences [63]. 
Introduction 
 
Figure 6: Contractile activity-induced molecular adaptations within skeletal muscle which lead to IMF and 
SS mitochondrial biogenesis and the expression of nuclear genes encoding mitochondrial proteins 
(NUGEMPs) [64]. 
 
According to Riva et al. [65], these SS and IMF subpopulations have also 
different cristae morphology and structure, with SS mitochondria presenting 
predominantly lamelliform cristae, while IMF has both lamellar and tubular shaped 
cristae (Figure 7) [22; 65]. 
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Figure 7: Osmium-extracted mitochondria. Strands in background 
are ribbons of agarose. (a): Cluster of SS with solely lamelliform 
cristae. Scale bar, 1μm. (b): SS with mostly lamelliform cristae. Scale 
bar, 0.5μm. (c): IMF with exclusevely tubular cristae. Scale bar, 0.5 
μm. (d): IMF with mainly lamelliform cristae. Scale bar, 0.5μm [65]. 
 
Each of these subpopulations also has different capacities for protein 
synthesis, biochemical functionality and mitochondrial respiration [63]. They 
present different lipid and protein compositions, giving them different densities [60; 
61; 62]. Some studies suggested the involvement of different regulatory 
mechanisms for mitochondrial biogenesis under different stimuli, suggesting that 
these mitochondrial subpopulations have a different role in the cell’s economy [20; 
22; 61; 64]. 
In the work of Kuznetsov et al. [63], it was shown that SS mitochondria 
exist densely packed under the sarcolemma (Figure 8) and seem to have a shielding 
function against ROS, protecting the cell from the high oxygen concentrations, 
suggestive of a higher oxidized state of SS mitochondria compared to IMF [66].  
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Figure 8: Organization of SS mitochondrial clusters in rat soleus muscle. Clusters of subsarcolemmal 
mitochondria are densely packed. Mitochondria located near the outer cell membrane demonstrate 
interconnections and mitochondrial network (arrows), whose are necessary to synchronize mitochondrial 
activities between contractions cycles and to share the metabolic feedback regulation of mitochondrial 
respiration via energy transfer networks. Soleus mitochondria were labeled with Rhod-2. Scale bars, 5 
μm [63]. 
 
Hood et al. [67] also described SS mitochondria as more unstable than the 
IMF subpopulation, making them more plastic to distinct stimuli as chronic muscle 
use or disuse and pathological conditions. 
 
1.5. Mitochondrial impairment in type 1 diabetes mellitus 
T1DM, also called juvenile or insulin-dependent diabetes, is a chronic and 
metabolic disease characterized by the autoimmune process targeting the β-cells in 
the islets of Langerhans, causing their destruction and dysfunction, diminishing the 
production of insulin, which allows the transport of glucose from the blood to the 
cells, resulting in an abnormal high level of glucose in blood and a deficiency of 
glucose within cells [2]. Glucose, as the main energy source of the organism, is 
necessary for cells functions, but when in low concentrations, it brings several 
complications to the normal performance of cells and tissues in the organism. 
Skeletal muscle is an extremely energy demanding tissue, highly reliant on 
mitochondrial oxidative metabolism, being its impairment associated with diabetic 
dysfunction [68]. Several studies suggest that hyperglycaemia leads to oxidative 
damage of muscle mitochondria, intrinsically associated with increased ROS 
production [69]. Being the most relevant cell source of ROS, mitochondria are at 
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the same time targets of its own ROS generation. Mitochondrial proteins and 
mtDNA are particularly prone to oxidative damage [70; 71]. These misfolded 
proteins lead to OXPHOS dysfunction, increasing ROS production that will 
damage more mitochondrial proteins, creating a vicious cycle of misfolded protein 
and ROS production, as represented in Figure 9. The accumulation of misfolded 
proteins within mitochondria will activate the mitochondrial upregulation response 
(UPR
mt
), increasing QC proteins, in order to balance the homeostasis [38]. This 
phenomenon was observed in various aging diseases. 
 
 
Figure 9: Relationship between mitochondrial protein folding, metabolism and dysfunction. 
Mitochondrial protein homeostasis depend upon a balance between deleterious aspects of cellular and 
organelle biology that can produce large amounts of misfolded proteins (blue boxes) and the protective 
mechanisms such as the QC machinery and the mitochondrial upregulation (UPR
mt
), that protect against 
the accumulation of misfolded or damaged proteins (orange boxes) [38]. 
 
In several studies, type 1 diabetes-induced mitochondrial alterations were 
observed at a morphological level, through microscopic techniques directly [62]. 
T1DM mitochondria have less density [72], show less cristae [73; 74], are in 
decreased number in liver and heart [74; 75], have an increased sectional area, 
observed using transmission electron microscopy [76], possibly resulted from 
mitochondrial swelling [74; 76]. These alterations are possibly related with the 
impairment of QC proteins and other mitochondrial proteins, making their study 
important for a better understanding of the molecular mechanisms underlying 
T1DM and its complications. 
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1.6. Objectives 
In order to get a deep insight into the molecular mechanisms underlying 
type 1 diabetes complications-induced mitochondriopathy in skeletal muscle, the 
general aim of our work was to study the regulatory role of proteolysis in OXPHOS 
organization and functionality in pure fractions of SS and IMF mitochondria 
isolated from gastrocnemius muscle of STZ-induced diabetic rats. In this sense, 
mitochondria morphology, respiratory chain complexes organization and 
functionality, proteolytic activity and the expression of specific proteins such as 
paraplegin, mitofilin and ATP synthase β was evaluated. 
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2. Material and Methods  
___________________________________________________________________
Material and Methods 
 
 
2.1. Animals 
The experimental protocol was performed using 20 Wistar male rats (Rattus 
norvegicus), 8 weeks old and weighting 200g, at the beginning of the experiments. 
The animals were randomly divided into two groups (n=10 per group): a control 
group, and a T1DM group. In order to induced T1DM, rats from the group with 
T1DM were injected intraperitoneally with a single injection of 60mg/Kg of 
streptozotocin (STZ) diluted in sodium citrate buffer (pH 4.5) [77] and the control 
group of rats were injected with the same volume of sodium citrate buffer. Twenty-
four hours after the STZ administration, the glycemia was evaluated and the 
animals were considered diabetic when the levels of blood glucose were higher than 
250mg/dL. During the experimental protocol, animals were housed in collective 
cages (2-3 rats per cage) and were maintained in a room at normal environment 
(21–22 °C; ~50–60% humidity) receiving food and water ad libitum in 12h 
light/dark cycles. After 4 months of STZ administration, the glycemia and was 
measured and the animals were sacrificed through cervical dislocation, and the 
gastrocnemius muscles were extracted for mitochondrial extraction. Pools of 
muscles from 3 or 4 rats (n=3) were performed. 
The experimental protocol followed the specifications and recommendations 
from the “Guide for Care and Use of Laboratory Animal” from the Institute for 
Laboratory Animal Research (ILAR 1996). 
 
2.2. Isolation of SS and IMF mitochondrial subpopulations 
Mitochondrial populations were isolated from the gastrocnemius muscle 
following the protocol described by Ferreira et al. [62]. All the procedures were 
performed on ice or below 4ºC. Muscle tissue was washed three times with 
extraction buffer (EB) (20mM 3-(N-morpholino)propanesulfonic acid (MOPS), 
110mM KCl, 1mM ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic 
acid (EGTA), pH 7.5). The tissue, after being minced with scissors, was incubated 
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in EB with 0.25mg/mL trypsin (Promega, Wisconsin, USA), during 25min on ice. 
Buffer was then replaced by EB with 10mg/mL of albumin fat-free (Sigma). The 
tissue was washed with EB and homogenized with a Potter homogenizer (Teflon 
pestle). Large cellular debris and nuclei were pelleted by centrifugation for 5min at 
1000xg. The resulting supernatant was centrifuged for 20min at 16000xg and the 
pellet was gently re-suspended in a small volume of sucrose buffer (SB) (250mM 
sucrose, 0.1mM EGTA, 10mM Tris-HCl, pH 7.4), to a final protein concentration 
of 8–15mg/mL and further purified on a density-gradient with 50% v/v Percoll 
(Sigma). After centrifugation at 95000xg for 30min, two mitochondrial 
subpopulations were obtained; a lower brown band, corresponding to IMF 
mitochondria, and an upper one consisting of SS mitochondria. The mitochondrial 
subpopulations were washed twice with SB and after final purification were 
aliquoted for electron microscopic analysis, BN-PAGE, respiratory chain 
complexes IV and V in-gel activity assays, zymography and western blot analysis. 
Protein content was determined with RC DC Protein Assay kit (Bio-Rad, Hercules, 
CA, USA) and DNA content was quantified with QubitTM fluorometer (Invitrogen, 
Carlsbad, CA, USA). 
 
2.3. Electron microscopic analysis and average mitochondrial area 
calculation 
For morphological characterization, 75μL of mitochondrial suspension of 
each subpopulation from both groups were centrifuged at 7000xg for 10 minutes 
and the resulting pellet was fixed with 2.5% gluteraldehyde, postfixed with 2% 
osmium tetroxide, dehydrated in graded ethanol and embedded in Epon. Ultra-thin 
(100nm) sections from mitochondrial suspensions were contrasted with uranyl 
acetate and lead citrate for TEM (transmission electron microscopy) analysis (Zeiss 
EM 10A). For mitochondria morphometric evaluation, photographs of ultrathin 
sections were digitalized and analyzed with the NIH Image J (Image Processing and 
Analysis in Java, USA) software. In each experiment, more than 150 mitochondria 
from SS and 800 mitochondria from IMF subpopulation suspension were analysed 
for organelle sectional area quantification.  
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2.4. BN-PAGE and in-gel activity of OXPHOS complexes IV and V 
BN-PAGE was performed using the method described by Schagger and von 
Jagow [78] with minor modifications. Mitochondria (200 g of total protein), from 
each mitochondrial subpopulation (duplicate of n=3), were pelleted by 
centrifugation at 20000xg for 10min and ressuspended with the solubilization 
buffer (50mM NaCl, 50mM Imidazole, 2mM ε-amino n-caproic acid, 1mM EDTA, 
pH 7.0) with 1% w/v digitonin. After 10min on ice, insoluble material was removed 
by centrifugation at 20000xg for 20min at 4ºC. Soluble components were combined 
with 0.5% w/v Coomassie Blue G250, 50mM -amino n-caproic acid, 4% w/v 
glycerol and separated on a 4–13% acrylamide gradient gel with 3.5% sample gel 
on top. Gels were run in a SE600 Electrophoresis Unit (Hoefer). Anode buffer 
(25mM Imidazole, pH 7.0) and cathode buffer (50mM tricine and 7.5mM 
Imidazole, pH 7.0) containing 0.02% w/v Coomassie Blue G250 was used during 
1h at 70V, the time needed for the dye front reach approximately one-third of the 
gel. Cathode buffer was then exchange for one with 0.002% w/v Coomassie Blue 
G250 and the native complexes were separated at 200V for 3h at 4ºC. Native 
standard markers (GE Healthcare) were used. The gels were stained with 0.12% 
w/v Coomassie Blue G250 prepared in 20% methanol, after 1 h fixation in a 
solution of 10% acetic acid and 40% methanol. Gels were then destained with 25% 
methanol and scanned with Gel Doc XR System (Bio-Rad). 
The in-gel activity and histochemical staining assays of complexes IV and V 
were determined using the methods described by Zerbetto et al. [79] with minor 
modifications. After the membrane complexes separation through BN-PAGE, 
complex IV-specific heme stain was determined using 10μL horse heart 
cytochrome c (5mM) and 0.5mg diaminobenzidine dissolved in 1mL 50mM 
sodium phosphate, pH 7.2. The reaction was stopped by 50% v/v methanol and 
10% v/v acetic acid, and the gels were then transferred to water. ATP hydrolysis 
activity of complex V was analyzed by incubating the BN-PAGE gels with 35mM 
Tris, 270mM glycine buffer, pH 8.3, at 37ºC, which had been supplemented with 
14mM MgSO4, 0.2% w/v Pb(NO3)2 and 8mM ATP. Lead phosphate precipitation 
that is proportional to the enzymatic ATP hydrolysis activity was stopped by 50% 
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v/v methanol (30min), and the gels were then transferred to water. Band detection, 
quantification and matching were performed using QuantityOne
®
 Imaging software 
(v4.6.3, Bio-Rad) as a function of density (intensity/mm
2
). The Volume Rectangle 
Tool was used to measure the total signal intensity inside a boundary drawn around 
the bands. Background was subtracted from each band volume by using local 
background subtraction. Intensities of bands acquired from each protein extract 
were compared and results were expressed as arbitrary units of optical density 
(OD). 
 
2.5. Protease activity analysis through gelatin zymography 
The zymographies were performed using a 10% SDS-PAGE separation gel 
with 0.1% of gelatin (n= 3). 40μg of each sample was incubated on charging buffer 
(100mM Tris pH 6.8, 5% SDS, 20% glycerol, 0.1% bromophenol blue) for 10 
minutes on ice, in a proportion of 1:1 (v/v). After separation, the gels were 
incubated in renaturation buffer (2.5% Triton X-100) for 30 minutes, with soft 
agitation. Then, the zymogram gels were changed to a development buffer (50mM 
Tris, 5mM NaCl, 10mM CaCl2, 1μm ZnCl2, 0.02% (v/v) Triton X-100, pH 7.4) for 
more 30 minutes, also with soft agitation. Finally, the gels were changed to a new 
development buffer, and incubated overnight at 37ºC. 
The zymography gels were stained with 0.12% w/v Coomassie Blue G250 
prepared in 20% methanol, after 1 hour fixation in a solution of 10% acetic acid and 
40% methanol. Gels were then destained with 25% methanol and scanned with Gel 
Doc XR System (Bio-Rad). 
 
2.6. Proteases identification from zymography and SDS-PAGE gels 
The zymography bands with proteolytic activity and the correspondent 
bands from the SDS gel were excised. The bands from the zymography were 
washed four times with 25mM of ammonium bicarbonate/ 50% acetonitrile, while 
the bands from the SDS were washed just two times. The dehydration of the bands 
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was performed with a final wash with 100% acetonitrile, followed by a drying in a 
SpeedVac
®
 Plus SC 210 A (Thermo Savant, USA). After dried, it was added 20μL 
of Trypsin (Catalogue #V511A, Promega Corporation, USA) in ammonium 
bicarbonate 25mM (concentration of Trypsin of 10μg/mL), and incubated for 1 
hour at 37ºC, in order to the gel absorb the maximum possible Trypsin, then 30μL 
of more ammonium bicarbonate 25mM was added, and a new incubation was 
performed overnight also at 37ºC. The digested peptides were extracted from the 
gel with 10% formic acid and concentrated under vacuum in the SpeedVac
®
 Plus 
SC 210 A (Thermo Savant, USA). Finally, the peptides were ressuspended in 10μL 
of 50% acetonitrile/ 0.1% formic acid solution, centrifuged for 5 minutes at 
15000rpm and transferred to a HPLC vial for peptide separation. 
The peptide separation through HPLC was performed in the separation 
module Ultimate 3000 (LC Pachings), using a capillary column (C18 Zorbax SB 
300; 0.75μm of internal diameter; 15cm length). A gradient was used from the A 
solvent – H2O/ acetonitrile/ trifluoracetic acid (95:5:0.05 v/v/v) – to the B solvent – 
H2O/ acetonitrile/ trifluoracetic acid (20/ 80/ 0.04 v/v/v). For the separation 2μg/μL 
of sample were injected. The separation was performed using a linear gradient (5-
55% B solution, for 30 minutes, 55-80% B solution for 10 minutes and 80-5% A 
solution for 5 minutes), each one with a flow of 0.3μL/min. After being eluted from 
the column, the peptides were directly applied into a MALDI plaque in 20 seconds 
fractions, using an automatic collector (LcPackings), with the addition of 270nL of 
α-ciano-4-hidroxicinâmic acid matrix (6mg/mL of α-ciano-4-hidroxicinâmic acid 
matrix prepared in 70% acetonitrile and 0.3 trifluoracetic acid, supplemented with 
0.4μL of a Glu-Fib solution (15fmol)) for later identification of the proteases 
detected through zymography. 
The mass spectra of the peptides resulted from the proteins tryptic digestion 
and HPLC separation, were obtained with a mass spectrometer MALDI-TOF/TOF 
(4800 Proteomics Analyzer, Applied Biosystems, Foster City, CA, USA), in 
positive reflectron mode and obtained in the mass interval between 700 and 
4500Da, with 1000 laser shots. It was created a data acquisition method to select 
the 10 most intense peaks in each spot for later MS/MS specter acquisition, 
excluding the matrix peaks due trypsin or acrylamide autolysis. The internal 
Type 1 diabetes mellitus effects on mitochondrial function 
25 
standard Glu-Fib peak (m/z1570.68Da) was used as internal calibrating of the 
equipment. The spectra were processed and analyzed by Global Protein Server 
(GPS) Workstation (Applied Biosystems), which uses as search engine the Mascot 
(Matrix Science, London, UK), for protein identification conjugated with the data 
of PMF (peptide mass fingerprinting), with the data of MS/MS for internal data 
base search. The protein identification was accepted when the confidence degree 
was bigger than 99%. 
 
2.7. Western Blot analysis 
Equal amounts of proteins from each mitochondrial population (duplicate of 
n=3) were electrophoresed on a 10% SDS-PAGE gel, followed by blotting on a 
nitrocellulose membrane (Hybond-ECL; Amersham Pharmacia Biotech, 
Buckinghamshire, UK). After blotting, non-specific binding was blocked with 5% 
w/v nonfat dry milk in TTBS (TBS ((tris-buffered saline) 100mM Tris, 1.5mM 
NaCl, pH 8.0) with 0.5% Tween-20) and the membrane was incubated with 
primary antibody (anti-paraplegin (H-180: sc-135026 Santa Cruz Biotechnology, 
INC. (CA, USA), anti-ATP synthase (cat. no. ab14730 Abcam (Cambridge, UK) or 
anti-mitofilin (cat. no. ab48139 Abcam (Cambridge, UK)), diluted 1:1000 in 5% 
w/v nonfat dry milk in TTBS for 2 h at room temperature, washed and incubated 
with secondary horseradish peroxidase-conjugated anti-mouse or anti-rabbit (GE 
Healthcare), respectively. The blots were developed by using enhanced 
chemiluminescence detection system (Amersham Pharmacia Biotech) according to 
the manufacturer’s instructions, followed by exposure to X-ray films (Sigma, 
Kodak Biomax Light Film, St. Louis, MO, USA). The protein bands on films were 
visualized using a GelDoc XR (Bio-Rad) and quantified by QuantityOne
®
 imaging 
software (v4.6.3, Bio-Rad) as explained above. 
 
2.8. Statistical analysis 
The optical densities of each protein band in BN-PAGE and zymograhy gels 
were exported, after normalization, from QuantityOne
®
 imaging software (v4.6.3, 
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Biorad), to GraphPad Prism 5, were the unpaired Student’s t-test was performed, 
using a 95% confidence degree, in order to evaluate the expressed differences 
between the two group (control and diabetic). 
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3. Results  
___________________________________________________________________
Results 
 
 
3.1. Validation of the experimental T1DM animal model 
In this study we used an animal model obtained by intraperitoneal 
administration of a single dose of 60mg/Kg streptozotocin (STZ). In order to 
validate the animal model, glycemia and glycated hemoglobin (HbA1c) were 
evaluated (Table 2). 
Table 2: Glicemia and HbA1c measured values for each group (control and type 1 
diabetes). The values are presented with mean ± standard deviation. 
 Glicemia (mg/dL) HbA1c (%) 
CONT 66.3 ± 15.0 3.96 ± 0.80 
T1DM 577.1 ± 234.0*** 6.28 ± 1.12*** 
***p<0.0001 vs. Control 
 
As can be observed in table 1, the rats from T1DM group showed a 
significantly higher concentration of blood glucose and glycated hemoglobin than 
the ones from the control group. 
The effect of STZ administration was also evaluated in terms of animals’ 
body weight and muscle mass (Table 3). 
Table 3: The effect of T1DM in rat body weight, gastrocnemius muscle mass and 
gastrocnemius muscle/ body weight ratio. The values are presented with mean ± standard 
deviation. 
 Body weight (g) Muscle weight (g) 
Muscle weight/body 
weight ratio (mg/g) 
CONT 437.1 ± 58.4 5.69 ± 0.04 13.03 ± 0.001 
T1DM 251.0 ± 43.1*** 3.99 ± 0.88** 15.90 ± 0.006 
***p<0.0001 vs. Control 
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As can be seen in table 2, muscle mass significantly decreased (29.9%) in 
T1DM rats, associated with a lower body weight (42.6%). So, the muscle mass/ 
body weight ratio presented no differences between the two groups of rats.  
The comparison of glycemia, Hb1Ac, muscle mass and body weight values 
between CONT and T1DM groups clearly evidence a diabetic status of T1DM rats. 
 
3.2. Evaluation of mtDNA and mitochondrial protein concentrations in 
skeletal muscle 
The levels of mtDNA and mitochondrial protein were quantified in IMF and 
SS mitochondria isolated from gastrocnemius muscle. The ratios protein/mtDNA 
concentrations, mtDNA content/muscle mass and protein/muscle mass were then 
determined (Table 4). The mtDNA concentration in the muscle was evaluated in 
order to obtain a rough value of the mitochondrial quantity in the muscle, with 
which values, was possible to calculate the percentage of each mitochondrial 
subpopulation in the muscle (Table 4). 
Table 4 Effects of T1DM in mitochondrial protein content-to-mtDNA concentration, mtDNA-to-muscle 
mass and protein content-to-muscle mass. The results are expressed as mean ± standard deviation.  
***p <0.0001 vs. Control SS; *p <0.05 vs. Control SS 
For both experimental groups, Table 4 shows no significant differences in 
the mitochondrial protein/mtDNA ratio. A tendency is noticed in control SS to be 
higher than the samples from diabetic SS, though with no statistical significance. 
Experimental 
Group 
[Protein]/[mtDNA] 
ratio (μg.mg-1) 
mtDNA/mmuscle (μg.g
-1
) Protein/mmuscle (mg.g
-1
) 
CONT 
SS 0.80 ± 0.454 0.11 ± 0.022 0.10 ± 0.069 
IMF 0.52 ± 0.318 0.48 ± 0.034 0.25 ± 0.044 
T1DM 
SS 0.56 ± 0.023 0.37 ± 0.014*** 0.21 ± 0.015* 
IMF 0.66 ± 0.079 0.54 ± 0.160 0.35 ± 0.117 
Results 
A significantly higher concentration of mtDNA/muscle mass was noticed in 
the SS subpopulation of T1DM compared to CONT. No differences were observed 
among IMF mitochondria from both groups. 
For both mitochondrial subpopulations, it was noticed a tendency for higher 
mitochondrial protein concentration in the muscles from diabetic rats, comparing 
with control ones. However, the only significant differences were observed for SS 
mitochondria (p value < 0.05) (Table 4). 
 
3.3. Morphological characterization of mitochondrial subpopulations 
In the mitochondria isolation procedure, after the final centrifugation in the 
Percoll gradient, two different mitochondrial subpopulations with different 
densities were obtained, corresponding to the two different brown bands observed 
(Figure 10). The upper band contains SS mitochondria and the lower band contains 
IMF mitochondria. 
  
Figure 10: Percoll gradient loaded with crude mitochondrial after 
ultracentrifugation. Density differences are evident between SS and IMF 
subpopulations, for both groups in study (CONT and T1DM). No visible 
differences are noticed between mitochondria from control and T1DM groups. 
 
Once removed from the Percoll, mitochondrial subpopulations were 
morphologically analysed by transmission electron microscopy (TEM). A general 
analysis of TEM images of SS populations showed a lot of membranes and few 
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mitochondria (Figure 11a and b); on the other hand, mitochondria with different 
shapes and sizes were noticed and no fragmented membranes or any kind of debris 
was seen in the IMF images (Figure 11c and d). 
The micrographs obtained were also used to calculate the mitochondria area 
(Figure 11e). 
  
Figure 11: TEM images from: (a) SS mitochondria from control rats, (b) SS mitochondria from T1DM 
rats, (c) IMF mitochondria from control rats and (d) IMF mitochondria from T1DM rats, with a 
magnification of 10,000x. (e) Box and whiskers graph where the mitochondrial area of the different 
populations is compared  (n=180 for SS and n=800 for IMF). Scale bar = 2 μm. 
***p < 0.0001 vs. C IMF 
 
Regarding the average area of each mitochondrial subpopulation in the 
different groups of rats, no significant difference between SS mitochondrial from 
control and diabetic rats (8.401 ± 0.2413μm2 and 8.092 ± 0.3122μm2, respectively) 
were observed; on the other hand, the statistical analysis evidenced a large 
difference in size between IMF mitochondria of control and T1DM groups, with 
smaller mitochondria observed in control rats than in T1DM (12.22 ± 0.1321μm2 to 
14.89 ± 0.1915μm2, p value < 0.0001). 
 
3.4. BN-PAGE and in gel activity of OXPHOS complexes IV and V 
In order to evaluate the effect of STZ administration on mitochondrial 
respiratory chain complexes organization, BN-PAGE analysis of mitochondrial 
subpopulations was performed. The representative BN-PAGE (Figure 12), show a 
hauling effect in both lanes with the SS samples (Figure 12a and b), confirmed by 
the wide peaks in the darker lanes on the right of Figure 12. No qualitative or 
Results 
quantitative differences of the overall band pattern were observed among isolated 
IMF mitochondria from both groups of study (Figure 12c and d). 
 
Figure 12: BN-PAGE profile of SS and IMF mitochondria. An overlap 
of the density variation of the four lanes is presented on the right. 
 
Regarding BN-PAGE separation of mitochondrial respiratory chain 
complexes (Figure 12), no differences were seen between CONT and T1DM groups 
for SS or IMF subpopulation. However, comparing SS with IMF mitochondria a 
slightly different profile was observed suggestive of a different organization of 
OXPHOS complexes. 
In order to evaluate OXPHOS functionality, the in-gel activity of complexes 
IV and V was determined. The in-gel activity of the CIV showed no quantitative 
differences between T1DM and controls, in both mitochondrial subpopulations, as 
can be observed in Figure 13a. 
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Figure 13: Effects of T1DM in the in-gel activity of respiratory chain complexes IV (a) and V (c) of 
mitochondrial subpopulations SS and IMF, with respective representative images (b+d). The OD results are 
expressed in arbitrary units (mean ± standard deviation). 
**p < 0.01 vs. Control SS 
Regarding CV, significant differences were only observed within SS 
subpopulation, with T1DM presenting lower activity than control groups (Figure 
13b). 
 
3.5. Gelatin zymography analysis 
The global analysis of mitochondrial proteolytic activity was performed by 
gelatin zymography. Two light bands were observed for each sample: one poorly 
visible upper band, with around 25KDa, and a more visible at a lower position in 
the gel, with around 15KDa (Figure 14a). These bands were extracted from 
zymography and corresponding SDS-PAGE gels and analysed by nLC-MS/MS for 
proteases identification. Nevertheless, no positive identifications were achieved due 
to technical problems.  
Results 
 
Figure 14: Effects of T1DM in the proteolytic activity of mitochondrial subpopulations (SS and IMF) (a) 
Representative image of the zymography evidencing two light bands with noticeable proteolytic activity. 
Comparison of OD variation for each band: the upper band (b) and the lower band (c). The OD results are 
expressed in arbitrary units (mean ± standard deviation). 
**p < 0.01 vs. Control IMF 
 
The analysis of OD variation among different subpopulations and groups 
was performed for each band with proteolytic activity. No differences were 
noticeable between both control and diabetic groups in the upper band, for both 
mitochondrial subpopulations (Figure 14b). On the other hand, for IMF 
mitochondria was visible a higher activity in the control group regarding the lower 
band (Figure 14c). 
 
3.6. Western blot analysis 
The expression of several proteins (ATP synthase subunit , paraplegin and 
mitofilin) was evaluated by western blotting. Regarding ATP synthase subunit , 
no differences between CONT and T1DM groups were observed, for both 
mitochondrial subpopulations (Figure 15).  
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Figure 15: (a) Effects of T1DM in the ATP synthase expression in the different mitochondrial 
subpopulations. The OD results are expressed in arbitrary units (mean ± standard deviation). 
(b) Representative image of the Western blot. 
 
The paraplegin analysis showed a different tendency between the two 
mitochondrial subpopulations (Figure 16), with higher OD values observed in 
T1DM group regarding SS subpopulation. In opposition, higher expression levels 
of this protease were noticed in the control group of IMF mitochondria, when 
compared to T1DM group (p value < 0.0001). 
 
Figure 16: Effects of T1DM in paraplegin expression in the different mitochondrial 
subpopulations (SS and IMF). The OD results are expressed in arbitrary units (mean ± 
standard deviation). (b) Representative image of the Western blot. 
*p< 0.05 vs. Control SS; ***p < 0.0001 vs. Control IMF 
 
The mitofilin analysis evidenced two very distinct bands in IMF samples, 
corresponding to the two mitofilin isoforms (Figure 17). No signal was detected in 
Results 
the immunoblots for SS mitochondrial samples. Only one OD value was considered 
in the analysis of mitofilin expression, corresponding to the sum of both bands’ OD 
(Figure 17). 
 
 
Figure 17: Effects of T1DM in mitofilin expression, in IMF 
mitochondrial subpopulation,. The OD results are expressed in 
arbitrary units (mean ± standard deviation). (b) Representative 
image of the Western blot. 
**p < 0.01 vs. Control IMF 
 
The control group showed significantly higher expression levels of mitofilin 
(p value < 0.01) than T1DM (40.9%). 
 
In a general overview, in the gastrocnemius from T1DM rats, IMF 
mitochondria presented the higher alterations, whereas SS mitochondria suffered 
minor alterations, with paraplegin upregulation and increased mitochondrial 
biogenesis, regarding mtDNA-to-muscle mass as a rough measure of mitochondrial 
concentration, showing a better adaptation of this subpopulation to type 1 diabetes 
than IMF mitochondria. 
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Diabetes mellitus has been described in several studies as the epidemy of 
XXI century [80; 81; 82]. The study of Shaw et al. [1], report that the incidence of 
diabetes mellitus has increased, and in 2010 affected 285 million people worldwide, 
with a tendency to increase to 439 million people until 2030. T1DM is the less 
studied type of diabetes mellitus, but it is urgent to better understand this disease, 
since it has an autoimmune origin and the patients have low life quality due to the 
complications that arise very early in their life. 
In order to mimic T1DM and its complications, Wistar rats were injected 
with a single dose of STZ (60mg/Kg). Streptozotocin (STZ) specifically attacks β 
cells, because it has a glucose-similar structure, which allows its recognition by 
Glut-2 transporters, being able to reach the cell nucleus, where this drug acts by 
destroying the cellular genome [83]. The high glycemia and HbA1c levels 
measured in the rats from the group with T1DM, together with the notorious 
polyuria and polydipsia presented by these animals during the experimental 
protocol, proved that STZ administration successfully induced T1DM (Table 2). 
These results were also supported by the observed muscle weight loss, and 
consequent body weight loss in the rats from the T1DM group (Table 3), in a 
similar way as previously reported [84; 85]. The unaltered muscle weight/ body 
weight ratio showed that body weight loss, in the rats with T1DM, was a 
consequence of muscle weight loss, in these animals. 
In order to evaluate if these phenotypic alterations were related with 
mitochondrial morphological and biochemical changes, the two mitochondria 
subpopulations were studied. The differences between the IMF mitochondria 
sectional areas were significant, with mitochondria from the T1DM group 
presenting higher values than the ones from the control group (Figure 11). These 
results are in accordance with the previously reported by Cester et al. [76], that 
noticed a T1DM-related mitochondrial volume increment, possibly a mitochondrial 
response to impaired respiration through the increase of the ratio surface area-to-
volume [86]. These changes in the IM might be related with mitofilin 
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underexpression (Figure 17), since this protein is responsible for cristae assembly 
[53], as well as paraplegin underexpression (Figure 16), a protease involved in 
OPA1 maturation, a dependent cristae morphogenesis within mitochondria, by 
keeping its cristae junctions [87]. 
In the gastrocnemius muscle from the control group, the measured 
percentage of each population is the same as described in literature [60], 
considering mtDNA-to-muscle mass content, with SS mitochondria corresponding 
to 19% of the total mitochondria in the muscle, and IMF mitochondria to 81% [60]. 
In T1DM rats, the percentage of mtDNA each population rose in SS mitochondria 
and, lowered in IMF mitochondrial subpopulation, suggestive of increased SS 
biogenesis. The higher adaptability of SS mitochondria [60], might be an 
explanation for the T1DM-induced increase content of this mitochondrial 
subpopulation. For better comprehend these results, further analysis are needed, for 
example, the relative quantification through Western blot of proteins responsible 
for mtDNA biogenesis, like Tfam [88].  
The BN-PAGE profile of SS and IMF mitochondrial subpopulations 
observed in the present study were different among each other (Figure 12). The 
noticeable feature is the presence of clearly more defined gel bands in IMF 
compared to SS subpopulation, with slight MW differences in each OXPHOS 
complex band. The OXPHOS profile of SS mitochondria noticed in BN-PAGE was 
different from the previously described [89], possibly justified by technical 
problems in the separation of SS mitochondria, which resulted in mitochondrial 
fractions of this subpopulation with lot of membranes and few mitochondria 
(Figure 11). On the other hand, no differences in the BN-PAGE profile were 
observed between the control and T1DM group, suggesting that OXPHOS 
assembly is not affected by T1DM. These results are supported by the western blot 
analysis of ATP synthase β, since no expression differences were observed between 
control and T1DM group (Figure 15). Regarding OXPHOS functionality, T1DM-
induced decrease of ATP synthase activity was detected in SS mitochondria, being 
the opposite of the previous report of Baseler et al. [90]. Considering the control 
samples, no differences of OXPHOS complexes IV and V in-gel activities between 
IMF and SS subpopulations were noticed (Figure 13). These results are not in 
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accordance with a previous work [89], that reported a higher in-gel activity of CIV 
in IMF mitochondria, possibly justified by the low purity of SS subfractions. 
As observed in Figure 13a, protein Quality Control (QC) system within 
mitochondria has a great importance in ATP synthesis and consequently in tissue 
bioenergetics [31]. The typical effector enzymes of protein homeostasis are 
molecular chaperones and proteases [91]. To evaluate the T1DM effect on 
mitochondrial proteolysis, gelatin zymography was performed (Figure 14). Two 
bands with activity were observed in SS and IMF mitochondria from CONT and 
T1DM groups in the zymography gel; however, the proteases present in those 
bands were not successfully identified by LC-MS/MS, due to technical problems. 
Nevertheless, considering the molecular weights, the protease present in the upper 
band might be Cathepsin, which has 29KDa, and was previously detected in human 
monocites, through gelatin zymography gel [92]. The protease present in the lower 
band might be a catalytic domain of Lon protease, since in a previous work from 
our group this peptide with ~15KDa was identified by LC-MS/MS in mitochondrial 
fractions (data not shown). Lon protease exists in the matrix with a function of 
degrading misfolded and non-assembled proteins and peptides in the matrix, 
including denaturated and carbonylated proteins, being aconitase a good example 
[93; 94]. Future work exploring the effect of T1DM on Lon expression will be 
relevant for a better comprehension of QC within mitochondria. 
Among the mitochondrial proteases with QC function, the AAA
+
 
superfamily of ATPases have the task to fold and assembly unfolded and misfolded 
proteins that can accumulate in each of these four compartments [38]. The hetero-
oligomeric m-AAA protease localized in the inner mitochondrial membrane [45], 
seem to be involved in the QC of inner membrane complexes [38]. To assess the 
effect of T1DM on m-AAA expression and relate it with OXPHOS organization 
and functionality, the expression of paraplegin, a subunit of m-AAA, was evaluated 
(Figure 16). An overexpression of paraplegin was observed in the SS mitochondrial 
subpopulation of diabetic rats, whereas lower levels were noticed in T1DM IMF 
subpopulation. An opposite profile was observed for the ratio of mitochondrial 
protein-to-mtDNA (Table 4), with lower values observed in T1DM SS 
mitochondria, and higher in the IMF subpopulation. Considering these two 
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observations and the fact that mitochondrial protein-to- mtDNA ratio gives a rough 
idea of the protein quantity per mitochondrion, the protein accumulation observed 
in IMF mitochondria from T1DM animals might be a consequence of the lower 
expression of m-AAA ATPases, or a lower QC proteins import within IMF 
mitochondria, as reported by Baseler et al. [90]. Since SS mitochondria are used to 
constant oxidative ambient [63], and adapt better and faster to pathophysiological 
conditions [67; 95], paraplegin overexpression can be seen as a SS response to 
T1DM, in order to eliminate damaged protein. In the other hand, the 
underexpression of paraplegin in IMF mitochondria from T1DM group might 
reflect the accumulation of misfolded and damaged proteins not eliminated due to 
the low levels of m-AAA, being paraplegin an important subunit of this QC system.  
In overall, our results evidence a higher susceptibility of gastrocnemius IMF 
mitochondria to T1DM manifested by morphological and biochemical alterations.  
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In order to get a deep insight into the molecular mechanisms underlying 
type 1 diabetes complications-induced mitochondriopathy in skeletal muscle, the 
two mitochondrial subpopulations were isolated from gastrocnemius and 
morphologically and biochemically analysed. Data obtained allowed to conclude 
that: 
 Four months of STZ treatment resulted in a notorious decrease of body and 
muscle mass compared to healthy animals, paralleled by significantly high 
glycemia and HbA1c levels. 
 SS biogenesis increased in T1DM animals. Based on mtDNA–to-muscle 
mass ratio, a rough measure of mitochondrial content, an increment of SS 
mitochondrial content within gastrocnemius muscle was observed, whereas 
an opposite effect was noticed in IMF mitochondria, paralleled by a T1DM-
related higher mitochondrial sectional area, lower levels of the cristae 
regulatory protein mitofilin and increased protein-to-mtDNA ratio, 
suggestive of protein accumulation within IMF mitochondria.  
 OXPHOS complexes organization was not affected by T1DM, although 
mitochondrial functionality seems compromised, based on in-gel activity 
data. 
 T1DM-related differences of the overall mitochondrial proteolytic activity 
were noticed, particularly notorious for IMF mitochondria, with 
significantly lower activity of a ~15KDa protease observed in diabetic rats. 
The levels of the subunit paraplegin from the m-AAA mitochondrial QC 
system were also lower in this mitochondrial population from diabetic 
animals. An opposite effect was observed for SS mitochondria.  
Taken together, after four months of STZ administration, evidences of 
mitochondrial plasticity were noticed for both mitochondrial subpopulations from 
gastrocnemius muscle, especially regarding their biogenesis. IMF was the most 
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affected mitochondrial subpopulation in skeletal muscle regarding T1DM-induced 
dysfunction. 
 
Conclusions 
46 
 47 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6. References  
_________________________________________________________________________ 
References 
48 
 
 
[1]J.E. Shaw, R.A. Sicree, P.Z. Zimmet, Global estimates of the prevalence of diabetes for 
2010 and 2030. Diabetes Res Clin Pract 87 (2010) 4-14. 
[2]S. Krause Mda, P.I. de Bittencourt, Jr., Type 1 diabetes: can exercise impair the 
autoimmune event? The L-arginine/glutamine coupling hypothesis. Cell Biochem 
Funct 26 (2008) 406-433. 
[3]M. Mihanovic, D. Bodor, S. Kezic, B. Restek-Petrovic, A. Silic, Differential diagnosis of 
psychotropic side effects and symptoms and signs of psychiatric disorders. 
Psychiatr Danub 21 (2009) 570-574. 
[4]J. Silverstein, G. Klingensmith, K. Copeland, L. Plotnick, F. Kaufman, L. Laffel, L. Deeb, M. 
Grey, B. Anderson, L.A. Holzmeister, N. Clark, Care of children and adolescents 
with type 1 diabetes: a statement of the American Diabetes Association. Diabetes 
Care 28 (2005) 186-212. 
[5]A.E. Kitabchi, G.E. Umpierrez, J.M. Miles, J.N. Fisher, Hyperglycemic crises in adult 
patients with diabetes. Diabetes Care 32 (2009) 1335-1343. 
[6]S.R. Patton, Adherence to diet in youth with type 1 diabetes. J Am Diet Assoc 111 
(2011) 550-555. 
[7]A.M. Jacobson, M. de Groot, J.A. Samson, The effects of psychiatric disorders and 
symptoms on quality of life in patients with type I and type II diabetes mellitus. 
Qual Life Res 6 (1997) 11-20. 
[8]R.C. Lee, Z. Wang, M. Heo, R. Ross, I. Janssen, S.B. Heymsfield, Total-body skeletal 
muscle mass: development and cross-validation of anthropometric prediction 
models. Am J Clin Nutr 72 (2000) 796-803. 
[9]T. Vellai, G. Vida, The origin of eukaryotes: the difference between prokaryotic and 
eukaryotic cells. Proc Biol Sci 266 (1999) 1571-1577. 
[10]A.M. Distler, J. Kerner, C.L. Hoppel, Proteomics of mitochondrial inner and outer 
membranes. Proteomics 8 (2008) 4066-4082. 
[11]M.W. Gray, G. Burger, B.F. Lang, Mitochondrial evolution. Science 283 (1999) 1476-
1481. 
[12]B.F. Lang, G. Burger, C.J. O'Kelly, R. Cedergren, G.B. Golding, C. Lemieux, D. Sankoff, 
M. Turmel, M.W. Gray, An ancestral mitochondrial DNA resembling a eubacterial 
genome in miniature. Nature 387 (1997) 493-497. 
[13]S.G. Andersson, A. Zomorodipour, J.O. Andersson, T. Sicheritz-Ponten, U.C. Alsmark, 
R.M. Podowski, A.K. Naslund, A.S. Eriksson, H.H. Winkler, C.G. Kurland, The 
genome sequence of Rickettsia prowazekii and the origin of mitochondria. Nature 
396 (1998) 133-140. 
[14]C.J. Wallace, I. Clark-Lewis, A rationale for the absolute conservation of Asn70 and 
Pro71 in mitochondrial cytochromes c suggested by protein engineering. 
Biochemistry 36 (1997) 14733-14740. 
[15]D.R. Green, Apoptotic pathways: the roads to ruin. Cell 94 (1998) 695-698. 
[16]H.M. McBride, M. Neuspiel, S. Wasiak, Mitochondria: more than just a powerhouse. 
Curr Biol 16 (2006) R551-560. 
[17]G. Hajnoczky, G. Csordas, S. Das, C. Garcia-Perez, M. Saotome, S. Sinha Roy, M. Yi, 
Mitochondrial calcium signalling and cell death: approaches for assessing the role 
of mitochondrial Ca2+ uptake in apoptosis. Cell Calcium 40 (2006) 553-560. 
[18]G. Mathy, F.E. Sluse, Mitochondrial comparative proteomics: strengths and pitfalls. 
Biochim Biophys Acta 1777 (2008) 1072-1077. 
Type 1 diabetes mellitus effects on mitochondrial function 
49 
[19]P.J. Adhihetty, V. Ljubicic, D.A. Hood, Effect of chronic contractile activity on SS and 
IMF mitochondrial apoptotic susceptibility in skeletal muscle. Am J Physiol 
Endocrinol Metab 292 (2007) E748-755. 
[20]T.R. Koves, R.C. Noland, A.L. Bates, S.T. Henes, D.M. Muoio, R.N. Cortright, 
Subsarcolemmal and intermyofibrillar mitochondria play distinct roles in 
regulating skeletal muscle fatty acid metabolism. Am J Physiol Cell Physiol 288 
(2005) C1074-1082. 
[21]A.M. Aerts, P. Zabrocki, G. Govaert, J. Mathys, D. Carmona-Gutierrez, F. Madeo, J. 
Winderickx, B.P. Cammue, K. Thevissen, Mitochondrial dysfunction leads to 
reduced chronological lifespan and increased apoptosis in yeast. FEBS Lett 583 
(2009) 113-117. 
[22]J.W. Palmer, B. Tandler, C.L. Hoppel, Biochemical properties of subsarcolemmal and 
interfibrillar mitochondria isolated from rat cardiac muscle. J Biol Chem 252 
(1977) 8731-8739. 
[23]G. Attardi, G. Schatz, Biogenesis of mitochondria. Annu Rev Cell Biol 4 (1988) 289-333. 
[24]M. Wang, X.C. Wang, Z.Y. Zhang, B. Mou, R.M. Hu, Impaired mitochondrial oxidative 
phosphorylation in multiple insulin-sensitive tissues of humans with type 2 
diabetes mellitus. J Int Med Res 38 (2010) 769-781. 
[25]R. Acin-Perez, P. Fernandez-Silva, M.L. Peleato, A. Perez-Martos, J.A. Enriquez, 
Respiratory active mitochondrial supercomplexes. Mol Cell 32 (2008) 529-539. 
[26]G. Lenaz, M.L. Genova, Structural and functional organization of the mitochondrial 
respiratory chain: a dynamic super-assembly. Int J Biochem Cell Biol 41 (2009) 
1750-1772. 
[27]D.C. Gautheron, Mitochondrial oxidative phosphorylation and respiratory chain: 
review. J Inherit Metab Dis 7 Suppl 1 (1984) 57-61. 
[28]R.A. Stuart, Supercomplex organization of the oxidative phosphorylation enzymes in 
yeast mitochondria. J Bioenerg Biomembr 40 (2008) 411-417. 
[29]H. Schagger, Respiratory chain supercomplexes of mitochondria and bacteria. Biochim 
Biophys Acta 1555 (2002) 154-159. 
[30]N.V. Dudkina, S. Sunderhaus, E.J. Boekema, H.P. Braun, The higher level of 
organization of the oxidative phosphorylation system: mitochondrial 
supercomplexes. J Bioenerg Biomembr 40 (2008) 419-424. 
[31]T. Tatsuta, T. Langer, Quality control of mitochondria: protection against 
neurodegeneration and ageing. EMBO J 27 (2008) 306-314. 
[32]G. Kroemer, L. Galluzzi, C. Brenner, Mitochondrial membrane permeabilization in cell 
death. Physiol Rev 87 (2007) 99-163. 
[33]M. Koppen, T. Langer, Protein degradation within mitochondria: versatile activities of 
AAA proteases and other peptidases. Crit Rev Biochem Mol Biol 42 (2007) 221-
242. 
[34]S.A. Detmer, D.C. Chan, Functions and dysfunctions of mitochondrial dynamics. Nat 
Rev Mol Cell Biol 8 (2007) 870-879. 
[35]J. Roth, G.H. Yam, J. Fan, K. Hirano, K. Gaplovska-Kysela, V. Le Fourn, B. Guhl, R. 
Santimaria, T. Torossi, M. Ziak, C. Zuber, Protein quality control: the who's who, 
the where's and therapeutic escapes. Histochem Cell Biol 129 (2008) 163-177. 
[36]S.H. Park, N. Bolender, F. Eisele, Z. Kostova, J. Takeuchi, P. Coffino, D.H. Wolf, The 
cytoplasmic Hsp70 chaperone machinery subjects misfolded and endoplasmic 
reticulum import-incompetent proteins to degradation via the ubiquitin-
proteasome system. Mol Biol Cell 18 (2007) 153-165. 
[37]B. Friguet, A.L. Bulteau, I. Petropoulos, Mitochondrial protein quality control: 
implications in ageing. Biotechnol J 3 (2008) 757-764. 
[38]B.M. Baker, C.M. Haynes, Mitochondrial protein quality control during biogenesis and 
aging. Trends Biochem Sci 36 (2011) 254-261. 
References 
50 
[39]K. Leonhard, B. Guiard, G. Pellecchia, A. Tzagoloff, W. Neupert, T. Langer, Membrane 
protein degradation by AAA proteases in mitochondria: extraction of substrates 
from either membrane surface. Mol Cell 5 (2000) 629-638. 
[40]H. Arlt, R. Tauer, H. Feldmann, W. Neupert, T. Langer, The YTA10-12 complex, an AAA 
protease with chaperone-like activity in the inner membrane of mitochondria. Cell 
85 (1996) 875-885. 
[41]M. Koppen, F. Bonn, S. Ehses, T. Langer, Autocatalytic processing of m-AAA protease 
subunits in mitochondria. Mol Biol Cell 20 (2009) 4216-4224. 
[42]K. Leonhard, J.M. Herrmann, R.A. Stuart, G. Mannhaupt, W. Neupert, T. Langer, AAA 
proteases with catalytic sites on opposite membrane surfaces comprise a 
proteolytic system for the ATP-dependent degradation of inner membrane 
proteins in mitochondria. EMBO J 15 (1996) 4218-4229. 
[43]M. Nolden, S. Ehses, M. Koppen, A. Bernacchia, E.I. Rugarli, T. Langer, The m-AAA 
protease defective in hereditary spastic paraplegia controls ribosome assembly in 
mitochondria. Cell 123 (2005) 277-289. 
[44]K. Esser, B. Tursun, M. Ingenhoven, G. Michaelis, E. Pratje, A novel two-step 
mechanism for removal of a mitochondrial signal sequence involves the mAAA 
complex and the putative rhomboid protease Pcp1. J Mol Biol 323 (2002) 835-
843. 
[45]E.I. Rugarli, T. Langer, Translating m-AAA protease function in mitochondria to 
hereditary spastic paraplegia. Trends Mol Med 12 (2006) 262-269. 
[46]T. Karlberg, S. van den Berg, M. Hammarstrom, J. Sagemark, I. Johansson, L. 
Holmberg-Schiavone, H. Schuler, Crystal structure of the ATPase domain of the 
human AAA+ protein paraplegin/SPG7. PLoS One 4 (2009) e6975. 
[47]K. Karata, T. Inagawa, A.J. Wilkinson, T. Tatsuta, T. Ogura, Dissecting the role of a 
conserved motif (the second region of homology) in the AAA family of ATPases. 
Site-directed mutagenesis of the ATP-dependent protease FtsH. J Biol Chem 274 
(1999) 26225-26232. 
[48]M. Nolden, B. Kisters-Woike, T. Langer, M. Graef, Quality control of proteins in the 
mitochondrion, in: I. Braakman, (Ed.), Chaperones, Springer Berlin / Heidelberg, 
2006, pp. 119-147. 
[49]N. Ishihara, Y. Fujita, T. Oka, K. Mihara, Regulation of mitochondrial morphology 
through proteolytic cleavage of OPA1. EMBO J 25 (2006) 2966-2977. 
[50]J.Y. Mun, T.H. Lee, J.H. Kim, B.H. Yoo, Y.Y. Bahk, H.S. Koo, S.S. Han, Caenorhabditis 
elegans mitofilin homologs control the morphology of mitochondrial cristae and 
influence reproduction and physiology. J Cell Physiol 224 (2010) 748-756. 
[51]S. Ehses, I. Raschke, G. Mancuso, A. Bernacchia, S. Geimer, D. Tondera, J.C. Martinou, 
B. Westermann, E.I. Rugarli, T. Langer, Regulation of OPA1 processing and 
mitochondrial fusion by m-AAA protease isoenzymes and OMA1. J Cell Biol 187 
(2009) 1023-1036. 
[52]C. Merkwirth, S. Dargazanli, T. Tatsuta, S. Geimer, B. Lower, F.T. Wunderlich, J.C. von 
Kleist-Retzow, A. Waisman, B. Westermann, T. Langer, Prohibitins control cell 
proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis 
in mitochondria. Genes Dev 22 (2008) 476-488. 
[53]G.B. John, Y. Shang, L. Li, C. Renken, C.A. Mannella, J.M. Selker, L. Rangell, M.J. 
Bennett, J. Zha, The mitochondrial inner membrane protein mitofilin controls 
cristae morphology. Mol Biol Cell 16 (2005) 1543-1554. 
[54]J. Xie, M.F. Marusich, P. Souda, J. Whitelegge, R.A. Capaldi, The mitochondrial inner 
membrane protein mitofilin exists as a complex with SAM50, metaxins 1 and 2, 
coiled-coil-helix coiled-coil-helix domain-containing protein 3 and 6 and DnaJC11. 
FEBS Lett 581 (2007) 3545-3549. 
Type 1 diabetes mellitus effects on mitochondrial function 
51 
[55]C. Gieffers, F. Korioth, P. Heimann, C. Ungermann, J. Frey, Mitofilin is a 
transmembrane protein of the inner mitochondrial membrane expressed as two 
isoforms. Exp Cell Res 232 (1997) 395-399. 
[56]G. Biolo, A. Gastaldelli, X.J. Zhang, R.R. Wolfe, Protein synthesis and breakdown in skin 
and muscle: a leg model of amino acid kinetics. Am J Physiol 267 (1994) E467-474. 
[57]H. Westerblad, J.D. Bruton, A. Katz, Skeletal muscle: energy metabolism, fiber types, 
fatigue and adaptability. Exp Cell Res 316 (2010) 3093-3099. 
[58]G.A. Dudley, P.C. Tullson, R.L. Terjung, Influence of mitochondrial content on the 
sensitivity of respiratory control. J Biol Chem 262 (1987) 9109-9114. 
[59]M. Koppen, M.D. Metodiev, G. Casari, E.I. Rugarli, T. Langer, Variable and tissue-
specific subunit composition of mitochondrial m-AAA protease complexes linked 
to hereditary spastic paraplegia. Mol Cell Biol 27 (2007) 758-767. 
[60]P.J. Adhihetty, V. Ljubicic, K.J. Menzies, D.A. Hood, Differential susceptibility of 
subsarcolemmal and intermyofibrillar mitochondria to apoptotic stimuli. Am J 
Physiol Cell Physiol 289 (2005) C994-C1001. 
[61]M. Takahashi, D.A. Hood, Protein import into subsarcolemmal and intermyofibrillar 
skeletal muscle mitochondria. Differential import regulation in distinct subcellular 
regions. J Biol Chem 271 (1996) 27285-27291. 
[62]R. Ferreira, R. Vitorino, R.M. Alves, H.J. Appell, S.K. Powers, J.A. Duarte, F. Amado, 
Subsarcolemmal and intermyofibrillar mitochondria proteome differences 
disclose functional specializations in skeletal muscle. Proteomics 10 (2010) 3142-
3154. 
[63]A.V. Kuznetsov, J. Troppmair, R. Sucher, M. Hermann, V. Saks, R. Margreiter, 
Mitochondrial subpopulations and heterogeneity revealed by confocal imaging: 
possible physiological role? Biochim Biophys Acta 1757 (2006) 686-691. 
[64]P.J. Adhihetty, I. Irrcher, A.M. Joseph, V. Ljubicic, D.A. Hood, Plasticity of skeletal 
muscle mitochondria in response to contractile activity. Exp Physiol 88 (2003) 99-
107. 
[65]A. Riva, B. Tandler, F. Loffredo, E. Vazquez, C. Hoppel, Structural differences in two 
biochemically defined populations of cardiac mitochondria. Am J Physiol Heart 
Circ Physiol 289 (2005) H868-872. 
[66]V.P. Skulachev, Mitochondrial filaments and clusters as intracellular power-
transmitting cables. Trends Biochem Sci 26 (2001) 23-29. 
[67]D.A. Hood, Invited Review: contractile activity-induced mitochondrial biogenesis in 
skeletal muscle. J Appl Physiol 90 (2001) 1137-1157. 
[68]A. Bonetto, F. Penna, M. Muscaritoli, V.G. Minero, F. Rossi Fanelli, F.M. Baccino, P. 
Costelli, Are antioxidants useful for treating skeletal muscle atrophy? Free Radic 
Biol Med 47 (2009) 906-916. 
[69]J.A. Lumini, J. Magalhaes, P.J. Oliveira, A. Ascensao, Beneficial effects of exercise on 
muscle mitochondrial function in diabetes mellitus. Sports Med 38 (2008) 735-
750. 
[70]O. Savu, V.G. Sunkari, I.R. Botusan, J. Grunler, A. Nikolsjkov, S.B. Catrina, Stability of 
mitochondrial DNA against reactive oxygen species (ROS) generated in diabetes. 
Diabetes Metab Res Rev (2011). 
[71]J. Hur, K.A. Sullivan, A.D. Schuyler, Y. Hong, M. Pande, D.J. States, H.V. Jagadish, E.L. 
Feldman, Literature-based discovery of diabetes- and ROS-related targets. BMC 
Med Genomics 3 (2010) 49. 
[72]K. Morino, K.F. Petersen, S. Dufour, D. Befroy, J. Frattini, N. Shatzkes, S. Neschen, M.F. 
White, S. Bilz, S. Sono, M. Pypaert, G.I. Shulman, Reduced mitochondrial density 
and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring 
of type 2 diabetic parents. J Clin Invest 115 (2005) 3587-3593. 
References 
52 
[73]T.T. Chao, C.D. Ianuzzo, R.B. Armstrong, J.T. Albright, S.E. Anapolle, Ultrastructural 
alterations in skeletal muscle fibers of streptozotocin-diabetic rats. Cell Tissue Res 
168 (1976) 239-246. 
[74]U.M. Marinari, R. Monacelli, D. Cottalasso, A. Novelli, Effects of alloxan diabetes and 
insulin on morphology and certain functional activities of mitochondria of the rat 
liver and heart. Acta Diabetol Lat 11 (1974) 296-314. 
[75]H. Bugger, S. Boudina, X.X. Hu, J. Tuinei, V.G. Zaha, H.A. Theobald, U.J. Yun, A.P. 
McQueen, B. Wayment, S.E. Litwin, E.D. Abel, Type 1 diabetic akita mouse hearts 
are insulin sensitive but manifest structurally abnormal mitochondria that remain 
coupled despite increased uncoupling protein 3. Diabetes 57 (2008) 2924-2932. 
[76]N. Cester, R.A. Rabini, E. Salvolini, R. Staffolani, A. Curatola, A. Pugnaloni, M.A. 
Brunelli, G. Biagini, L. Mazzanti, Activation of endothelial cells during insulin-
dependent diabetes mellitus: a biochemical and morphological study. Eur J Clin 
Invest 26 (1996) 569-573. 
[77]H. Haacke, [Induction of diabetes mellitus of various degree of severity using 
streptozotocin in rats]. Klin Wochenschr 47 (1969) 437-438. 
[78]H. Schagger, G. von Jagow, Blue native electrophoresis for isolation of membrane 
protein complexes in enzymatically active form. Anal Biochem 199 (1991) 223-
231. 
[79]E. Zerbetto, L. Vergani, F. Dabbeni-Sala, Quantification of muscle mitochondrial 
oxidative phosphorylation enzymes via histochemical staining of blue native 
polyacrylamide gels. Electrophoresis 18 (1997) 2059-2064. 
[80]C. Martineau, [Diabetes mellitus, a stammering epidemic]. Soins (2008) S1. 
[81]A. Martinez-Castelao, [Clinical and social impact of the diabetes mellitus epidemic]. 
Nefrologia 28 (2008) 245-248. 
[82]R. Ostermann-Myrau, [Diabetes mellitus: an epidemic rise?]. Versicherungsmedizin 60 
(2008) 63-65. 
[83]M. Elsner, B. Guldbakke, M. Tiedge, R. Munday, S. Lenzen, Relative importance of 
transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. 
Diabetologia 43 (2000) 1528-1533. 
[84]J. Lumini-Oliveira, J. Magalhaes, C.V. Pereira, A.C. Moreira, P.J. Oliveira, A. Ascensao, 
Endurance training reverts heart mitochondrial dysfunction, permeability 
transition and apoptotic signaling in long-term severe hyperglycemia. 
Mitochondrion 11 (2011) 54-63. 
[85]T. Szkudelski, The mechanism of alloxan and streptozotocin action in B cells of the rat 
pancreas. Physiol Res 50 (2001) 537-546. 
[86]F. Ferreirinha, A. Quattrini, M. Pirozzi, V. Valsecchi, G. Dina, V. Broccoli, A. Auricchio, 
F. Piemonte, G. Tozzi, L. Gaeta, G. Casari, A. Ballabio, E.I. Rugarli, Axonal 
degeneration in paraplegin-deficient mice is associated with abnormal 
mitochondria and impairment of axonal transport. J Clin Invest 113 (2004) 231-
242. 
[87]C. Frezza, S. Cipolat, O. Martins de Brito, M. Micaroni, G.V. Beznoussenko, T. Rudka, D. 
Bartoli, R.S. Polishuck, N.N. Danial, B. De Strooper, L. Scorrano, OPA1 controls 
apoptotic cristae remodeling independently from mitochondrial fusion. Cell 126 
(2006) 177-189. 
[88]B. Chabi, P.J. Adhihetty, V. Ljubicic, D.A. Hood, How is mitochondrial biogenesis 
affected in mitochondrial disease? Med Sci Sports Exerc 37 (2005) 2102-2110. 
[89]A.I. Padrao, R.M. Ferreira, R. Vitorino, R.M. Alves, M.J. Neuparth, J.A. Duarte, F. 
Amado, OXPHOS susceptibility to oxidative modifications: The role of heart 
mitochondrial subcellular location. Biochim Biophys Acta (2011). 
[90]W.A. Baseler, E.R. Dabkowski, C.L. Williamson, T.L. Croston, D. Thapa, M.J. Powell, T.T. 
Razunguzwa, J.M. Hollander, Proteomic alterations of distinct mitochondrial 
Type 1 diabetes mellitus effects on mitochondrial function 
53 
subpopulations in the type 1 diabetic heart: contribution of protein import 
dysfunction. Am J Physiol Regul Integr Comp Physiol 300 (2011) R186-200. 
[91]T. Bender, C. Leidhold, T. Ruppert, S. Franken, W. Voos, The role of protein quality 
control in mitochondrial protein homeostasis under oxidative stress. Proteomics 
10 (2010) 1426-1443. 
[92]W.A. Li, Z.T. Barry, J.D. Cohen, C.L. Wilder, R.J. Deeds, P.M. Keegan, M.O. Platt, 
Detection of femtomole quantities of mature cathepsin K with zymography. Anal 
Biochem 401 (2010) 91-98. 
[93]D.A. Bota, J.K. Ngo, K.J. Davies, Downregulation of the human Lon protease impairs 
mitochondrial structure and function and causes cell death. Free Radic Biol Med 
38 (2005) 665-677. 
[94]E. Gur, R.T. Sauer, Recognition of misfolded proteins by Lon, a AAA(+) protease. Genes 
Dev 22 (2008) 2267-2277. 
[95]H. Hoppeler, Exercise-induced ultrastructural changes in skeletal muscle. Int J Sports 
Med 7 (1986) 187-204. 
 
 
